Vascular-water-exchange MRI (VEXI) enables the detection of subtle AXR alterations in Alzheimer's disease without MRI contrast agent, which may relate to BBB integrity
Abstracts: Blood-brain barrier (BBB) impairment is an important pathophysiological process in Alzheimer's disease (AD) and a potential biomarker for early diagnosis of AD. However, most current neuroimaging methods assessing BBB function need the injection of exogenous contrast agents (or trace...
Main Authors: | Yifan Zhang, Yue Wang, Zhaoqing Li, Zejun Wang, Juange Cheng, Xiaoyan Bai, Yi-Cheng Hsu, Yi Sun, Shiping Li, Jiong Shi, Binbin Sui, Ruiliang Bai |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-04-01
|
Series: | NeuroImage |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1053811923000976 |
Similar Items
-
Age- and time-of-day dependence of glymphatic function in the human brain measured via two diffusion MRI methods
by: Guangxu Han, et al.
Published: (2023-05-01) -
Implementing with intention: advantages, challenges, and tactics to optimally utilize the AXR metric
by: Alyssa Y. Castillo, et al.
Published: (2025-01-01) -
Impact of COVID-19 on urgent care diagnoses and the new AXR metric
by: Adam L. Hersh, et al.
Published: (2024-01-01) -
Dextran-enhanced CEST MRI reveals the size effect of BBB dysfunction associated with neuroinflammation
by: Wenshen Wang, et al.
Published: (2022-11-01) -
Apremilast exerts protective effects on stroke outcomes and blood–brain barrier (BBB) dysfunction through regulating Rho‐associated protein kinase 2 expression
by: Mingyuan Wang, et al.
Published: (2022-09-01)